Visual function in patients on ethambutol therapy for tuberculosis

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 2, 2012, Pages 174-178

  Kandel, Himal ^a   Adhikari, Prakash ^b   Shrestha, Gauri S ^b   Ruokonen, Eeva Liisa ^c   Shah, Dev Narayan ^b  

^a Eye Care Pvt Ltd   (Maldives)

^b TRIBHUVAN UNIVERSITY   (Nepal)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL;

ADULT; ANTERIOR EYE SEGMENT; ARTICLE; BINOCULAR VISION; CLINICAL ARTICLE; COLOR VISION; CONTRAST SENSITIVITY; DIRECTLY OBSERVED THERAPY; DRUG EFFECT; ELECTRORETINOGRAPHY; EYE TOXICITY; FEMALE; HUMAN; LATENT PERIOD; MALE; MONOCULAR VISION; PATIENT MONITORING; PERIMETRY; POSTERIOR EYE SEGMENT; PRIMARY TUBERCULOSIS; PROSPECTIVE STUDY; SIDE EFFECT; VISION; VISUAL ACUITY; VISUAL FIELD;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; COLOR VISION; ETHAMBUTOL; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS; VISION, OCULAR; VISUAL ACUITY; VISUAL FIELDS; YOUNG ADULT;

EID: 84859413431     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0095     Document Type: Article

References (27)

1. World Health Organization. World Health Report 2000: Health Systems: Improving Performance. Geneva, World Health Organization, 2000.
2. Menon, V., Jain, D., Saxena, R., and Sood, R. Prospective evaluation of visual function for early detection of etham-butol toxicity. Br. J. Ophthalmol. 93:1251-1254, 2009.
3. Melamud, A., Kosmorksy, G.S., and Lee, M.S. Ocular eth-ambutol toxicity. May. Clin Proc. 78:1409-1411, 2003.
4. Franunfelder, F.W., Sadun, A.A., and Wood, T. Update on ethambutol optic neuropathy. Expert Opin. Drug Saf. 5:615-618, 2006. (Pubitemid 44322879)
5. Sadun, A.A., Win, P.H., Ross-Cisneros, F.N., et al. Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans. Am. Ophthalmol. Soc. 98:223-232, 2000.
6. Rong-Kung, T., and Ying-Hsun, L. Reversibility of etham-butol optic neuropathy. J. Ocul. Pharmacol. Ther. Oct; 13:473-477, 1997.
7. Woung, L.C., Jou, J.R., and Liaw, S.L. Visual function in recovered ethambutol optic neuropathy. J. Ocular. Pharmacol. Ther. 11:411-419, 1995.
8. Chan, R.Y.C., and Kwok, A.K.H. Ocular toxicity of etham-butol. Hong. Kong. Med. J. 12:56-60, 2006.
9. Chatterjee, V.K., Buchanan, D.R., Friedmann, A.I., and Green, M. Ocular toxicity following ethambutol in standard dosage. Br. J. Dis. Chest. 80:288-291, 1986. (Pubitemid 16070438)
10. Schild, H.S., and Fox, B.C. Rapid-onset reversible ocular toxicity from ethambutol therapy. Am. J. Med. 90:404-406, 1991.
11. Tsai, R.K., and Lee, Y.H. Reversibility of ethambutol optic neuropathy. J. Ocul. Pharmacol. Ther. 13:473-477, 1997.
12. Choi, S.Y., and Hwang, J.M. Optic neuropathy associated with ethambutol in Koreans. Korean J. Ophthalmol. 11:106-110, 1997.
13. Hood, D.C., Bach, M., Brigell, M., Keating, D., Kondo, M., Lyons, J.S., et al. ISCEV Guidelines for Clinical Multifocal Electroretinography, 2007 edition; Available from www.ISCEV.org/standards [cited 2011 October 23].
14. Roland Consult. System Manual for RETIscan. Brandenburg, Germany.
15. Carr, R.E., and Henkind, P. Ocular manifestations of eth-ambutol. Arch. Ophthalmol. 67:566-571, 1962.
16. Woods, R.L., Tregear, S.J., and Mitchell, R.A. Screening for ophthalmic disease in older subjects using visual acuity and contrast sensitivity. Ophthalmology 105:2318-2326, 1998. (Pubitemid 30191678)
17. Elliott, D.B., Sanderson, K., and Conkey, A. The reliability of the Pelli-Robson contrast sensitivity chart. Ophthalmic Phy-siol. Opt. 10:21-24, 1990. (Pubitemid 20124574)
18. Polak, B.C., Leys, M., and van Lith, G.H. Blue-yellow colour vision changes as early symptoms of ethambutol oculotoxi-city. Ophthalmologica 191:223-236, 1985.
19. Yiannikas, C., Walsh, J.C., and Mcleod, J.G. Visual evoked potentials in the detection of subclinical optic toxic effects secondary to ethambutol. Arch. Neurol. 40:645-648, 1983. (Pubitemid 13009183)
20. Petrera, J.E., Fledelius, H.C., and Trojaborg, W. Serial pattern evoked potential recording in a case of toxic optic neuropathy due to ethambutol. Electroencephalogr. Clin. Neurophy-siol. 71:146-149, 1988. (Pubitemid 18056589)
21. Citron, K.M. Ethambutol: a review with special reference to ocular toxicity. Tubercle 50(Suppl):32-36, 1969.
22. Kakisu, Y., Adachi-Usami, E., and Mizota, A. Pattern elec-troretinogram and visual evoked cortical potential in eth-ambutol optic neuropathy. Doc. Ophthalmol. 67:327-334, 1987. (Pubitemid 18091301)
23. Hennekes, R. Clinical ERG findings in ethambutol intoxication. Graefes Arch. Clin. Exp. Ophthalmol. 218:319-321, 1982. (Pubitemid 12070682)
24. Yen, M.Y., Wang, A.G., Chiang, S.C., et al. Ethambutol retinal toxicity: an electrophysiologic study. J. Formos. Med. Assoc. 99:630-634, 2000.
25. Kohler, K., Zrenner, E., and Weiler, R. Ethambutol alters spinule-type synaptic connections and induces morphologic alterations in the cone pedicles of the fish retina. Invest. Ophthalmol. Vis. Sci. 36:1046-1055, 1995.
26. Marmor, M.F., Hood, D.C., Keating, D., et al. Guidelines for basic multifocal electroretinography (mffERG). Doc. Oph-thalmol. 106:105-115, 2003. (Pubitemid 36355951)
27. Hood, D.C., Odel, J.G., Chen, C.S., et al. The multifocal electroretinogram. J. Neuroophthalmol. 23:225-235, 2003. (Pubitemid 37158738)